logo
Select company
Select metric
56.19%Cash to Assets Ratio
VS
Market
93
Sector
76
Industry
66
History
46
$ 10.36Close
$ 2.49 - $ 10.63 52-Week Range
Ticker Information

Ticker

TRVI

Company Name

TREVI THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TREVI THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TRVI - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 208.34M$ 117.06M56.19%
3/31/2025$ 107M$ 19.37M18.11%
12/31/2024$ 110.9M$ 34.1M30.75%
9/30/2024$ 68.91M$ 16.05M23.29%
6/30/2024$ 73.81M$ 12.96M17.56%
3/31/2024$ 78.56M$ 13.81M17.58%
12/31/2023$ 89.4M$ 32.4M36.24%
9/30/2023$ 95.9M$ 25.96M27.08%
6/30/2023$ 100.98M$ 13.75M13.62%
3/31/2023$ 116.2M$ 11.65M10.03%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for TREVI THERAPEUTICS INC is calculated as follows: CashnEq [ $ 53.29M ] / Assets [ $ 55.88M ]
(=) Cash to Assets [ 95.37% ]

TRVI - Cash to Assets Ratio, Last 5 years

10.03%

Minimum

Mar 31, 2023

96.98%

Maximum

Mar 31, 2021

50.4%

Average

33.49%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%